Detection of COVID-19 in Saliva Collection

Centre Hospitalier Universitaire, Amiens501 enrolled

Overview

Since December 2019, the world has faced a pandemic of COVID-19, an infectious disease caused by SARS-CoV-2, a virus that emerged in China. The reference diagnosis is based on the search for the SARS-COV-2 genome in the nasopharyngeal sample. Carrying out this sample requires the competence of a healthcare professional and presents some inconveniences for the tested patient. Because saliva collection is simple, non-invasive, painless and inexpensive, and can be performed by poorly trained personnel, it could be an alternative to the reference nasopharyngeal sample. SARS-CoV2 detection in human saliva could be a potential diagnosis of COVID infection.

Study Type

OBSERVATIONAL

Enrollment

501

Conditions

Sars-CoV2 RT-PCR Saliva Collection Nasopharyngeal Sample

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patient hospitalized at the Amiens CHU in a COVID-19 unit * patient seen as outpatient in the area of infectious pathologies for COVID-19 infection Exclusion Criteria: * Patients under 18 * patients under guardianship or curators

Locations (1)

Outcomes

Primary Outcomes

Detection of SARS-CoV-2 RNA in the saliva sample

Time frame: day 1

Concordance between the Saliva sample and the nasonasopharyngeal sample SARS-CoV-2 RT-PCR results

Time frame: day 1